📰 Breakthrough Device News
Page 21 - Breakthrough Device News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Breakthrough Device. Real-time updates on events, politics, business and more.
November 4, 2022
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 03, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine...
November 2, 2022
SAN DIEGO, Nov. 2, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its second qua...
November 2, 2022
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...
November 2, 2022
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...
October 28, 2022
/PRNewswire/ -- W. L. Gore & Associates (Gore) today announced the first implants of its investigational GORE® VIAFORT Vascular Stent as part of the recently...
October 28, 2022
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA updated the...
October 28, 2022
CAUTION: Investigational device. Limited by United States law to investigational use. W. L. Gore & Associates initiates its GORE VIAFORT Device Pivotal Clinical Study for the treatment
October 26, 2022
FDA officials want to expand the Breakthrough Devices Program's scope to include devices improving accessibility and promoting health equity.
October 18, 2022
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Tuesday, the FDA issued an...
October 18, 2022
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Tuesday, the FDA issued an...